Literature DB >> 21524689

Long-term deficiency of circulating and hippocampal insulin-like growth factor I induces depressive behavior in adult mice: a potential model of geriatric depression.

M Mitschelen1, H Yan, J A Farley, J P Warrington, S Han, C B Hereñú, A Csiszar, Z Ungvari, L C Bailey-Downs, C E Bass, W E Sonntag.   

Abstract

Numerous studies support the hypothesis that deficiency of insulin-like growth factor I (IGF-1) in adults contributes to depression, but direct evidence is limited. Many psychological and pro-cognitive effects have been attributed to IGF-1, but appropriate animal models of adult-onset IGF-1 deficiency are lacking. In this study, we use a viral-mediated Cre-loxP system to knockout the Igf1 gene in either the liver, neurons of the CA1 region of the hippocampus, or both. Knockout of liver Igf1 reduced serum IGF-1 levels by 40% and hippocampal IGF-1 levels by 26%. Knockout of Igf1 in CA1 reduced hippocampal IGF-1 levels by 13%. The most severe reduction in hippocampal IGF-1 occurred in the group with knockouts in both liver and CA1 (36% reduction), and was associated with a 3.5-fold increase in immobility in the forced swim test. Reduction of either circulating or hippocampal IGF-1 levels did not alter anxiety measured in an open field and elevated plus maze, nor locomotion in the open field. Furthermore, local compensation for deficiencies in circulating IGF-1 did not occur in the hippocampus, nor were serum levels of IGF-1 upregulated in response to the moderate decline of hippocampal IGF-1 caused by the knockouts in CA1. We conclude that adult-onset IGF-1 deficiency alone is sufficient to induce a depressive phenotype in mice. Furthermore, our results suggest that individuals with low brain levels of IGF-1 are at increased risk for depression and these behavioral effects are not ameliorated by increased local IGF-1 production or transport. Our study supports the hypothesis that the natural IGF-1 decline in aging humans may contribute to geriatric depression.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21524689      PMCID: PMC3101268          DOI: 10.1016/j.neuroscience.2011.04.032

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  59 in total

1.  Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects.

Authors:  Brian A Hoshaw; Jessica E Malberg; Irwin Lucki
Journal:  Brain Res       Date:  2005-03-10       Impact factor: 3.252

2.  Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain.

Authors:  Cassia N Cearley; John H Wolfe
Journal:  Mol Ther       Date:  2006-01-18       Impact factor: 11.454

3.  Neurobehavioral and quality of life changes associated with growth hormone insufficiency after complicated mild, moderate, or severe traumatic brain injury.

Authors:  Daniel F Kelly; David L McArthur; Harvey Levin; Shana Swimmer; Joshua R Dusick; Pejman Cohan; Christina Wang; Ronald Swerdloff
Journal:  J Neurotrauma       Date:  2006-06       Impact factor: 5.269

4.  Subregional hippocampal deformations in major depressive disorder.

Authors:  James Cole; Arthur W Toga; Cornelius Hojatkashani; Paul Thompson; Sergi G Costafreda; Anthony J Cleare; Steven C R Williams; Edward T Bullmore; Jan L Scott; Martina T Mitterschiffthaler; Nicholas D Walsh; Catherine Donaldson; Mubeena Mirza; Andre Marquand; Chiara Nosarti; Peter McGuffin; Cynthia H Y Fu
Journal:  J Affect Disord       Date:  2010-04-14       Impact factor: 4.839

5.  Neuronal activity drives localized blood-brain-barrier transport of serum insulin-like growth factor-I into the CNS.

Authors:  Takeshi Nishijima; Joaquin Piriz; Sylvie Duflot; Ana M Fernandez; Gema Gaitan; Ulises Gomez-Pinedo; Jose M Garcia Verdugo; Felix Leroy; Hideaki Soya; Angel Nuñez; Ignacio Torres-Aleman
Journal:  Neuron       Date:  2010-09-09       Impact factor: 17.173

6.  Insulin-like growth factor I interfaces with brain-derived neurotrophic factor-mediated synaptic plasticity to modulate aspects of exercise-induced cognitive function.

Authors:  Q Ding; S Vaynman; M Akhavan; Z Ying; F Gomez-Pinilla
Journal:  Neuroscience       Date:  2006-05-02       Impact factor: 3.590

Review 7.  Role of neurotrophic factors in the etiology and treatment of mood disorders.

Authors:  Ronald S Duman
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

8.  The impact of depressive symptoms and chronic diseases on active life expectancy in older Americans.

Authors:  Sandra L Reynolds; William E Haley; Nonna Kozlenko
Journal:  Am J Geriatr Psychiatry       Date:  2008-05       Impact factor: 4.105

9.  The hormonal action of IGF1 in postnatal mouse growth.

Authors:  Elias Stratikopoulos; Matthias Szabolcs; Ioannis Dragatsis; Apostolos Klinakis; Argiris Efstratiadis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-25       Impact factor: 11.205

10.  A critical role for IGF-II in memory consolidation and enhancement.

Authors:  Dillon Y Chen; Sarah A Stern; Ana Garcia-Osta; Bernadette Saunier-Rebori; Gabriella Pollonini; Dhananjay Bambah-Mukku; Robert D Blitzer; Cristina M Alberini
Journal:  Nature       Date:  2011-01-27       Impact factor: 49.962

View more
  38 in total

1.  Circulating IGF1 regulates hippocampal IGF1 levels and brain gene expression during adolescence.

Authors:  Han Yan; Matthew Mitschelen; Georgina V Bixler; Robert M Brucklacher; Julie A Farley; Song Han; Willard M Freeman; William E Sonntag
Journal:  J Endocrinol       Date:  2011-07-12       Impact factor: 4.286

2.  Brain regional angiogenic potential at the neurovascular unit during normal aging.

Authors:  Nivetha Murugesan; Tyler G Demarest; Joseph A Madri; Joel S Pachter
Journal:  Neurobiol Aging       Date:  2011-10-21       Impact factor: 4.673

3.  Hypertension-induced synapse loss and impairment in synaptic plasticity in the mouse hippocampus mimics the aging phenotype: implications for the pathogenesis of vascular cognitive impairment.

Authors:  Zsuzsanna Tucsek; M Noa Valcarcel-Ares; Stefano Tarantini; Andriy Yabluchanskiy; Gábor Fülöp; Tripti Gautam; Albert Orock; Anna Csiszar; Ferenc Deak; Zoltan Ungvari
Journal:  Geroscience       Date:  2017-06-29       Impact factor: 7.713

Review 4.  Lifelong consequences of brain injuries during development: From risk to resilience.

Authors:  Zachary M Weil; Kate Karelina
Journal:  Front Neuroendocrinol       Date:  2019-09-24       Impact factor: 8.606

5.  Circulating anti-geronic factors from heterochonic parabionts promote vascular rejuvenation in aged mice: transcriptional footprint of mitochondrial protection, attenuation of oxidative stress, and rescue of endothelial function by young blood.

Authors:  Tamas Kiss; Stefano Tarantini; Tamas Csipo; Priya Balasubramanian; Ádám Nyúl-Tóth; Andriy Yabluchanskiy; Jonathan D Wren; Lori Garman; Derek M Huffman; Anna Csiszar; Zoltan Ungvari
Journal:  Geroscience       Date:  2020-03-15       Impact factor: 7.713

6.  Co-treatment of vitamin D supplementation with enriched environment improves synaptic plasticity and spatial learning and memory in aged rats.

Authors:  Mahnaz Bayat; Kristi A Kohlmeier; Masoud Haghani; Afshin Borhani Haghighi; Azadeh Khalili; Gholamreza Bayat; Etrat Hooshmandi; Mohammad Shabani
Journal:  Psychopharmacology (Berl)       Date:  2021-05-15       Impact factor: 4.530

Review 7.  Neuroendocrine drivers of risk and resilience: The influence of metabolism & mitochondria.

Authors:  Susie Turkson; Alix Kloster; Peter J Hamilton; Gretchen N Neigh
Journal:  Front Neuroendocrinol       Date:  2019-07-06       Impact factor: 8.606

Review 8.  Chemically induced carcinogenesis in rodent models of aging: assessing organismal resilience to genotoxic stressors in geroscience research.

Authors:  Anna Csiszar; Priya Balasubramanian; Stefano Tarantini; Andriy Yabluchanskiy; Xin A Zhang; Zsolt Springo; Doris Benbrook; William E Sonntag; Zoltan Ungvari
Journal:  Geroscience       Date:  2019-04-29       Impact factor: 7.713

Review 9.  Connective tissue growth factor (CTGF) in age-related vascular pathologies.

Authors:  Zoltan Ungvari; Marta Noa Valcarcel-Ares; Stefano Tarantini; Andriy Yabluchanskiy; Gábor A Fülöp; Tamas Kiss; Anna Csiszar
Journal:  Geroscience       Date:  2017-09-05       Impact factor: 7.713

10.  Endothelin-1-induced focal cerebral ischemia in the growth hormone/IGF-1 deficient Lewis Dwarf rat.

Authors:  Han Yan; Matthew Mitschelen; Peter Toth; Nicole M Ashpole; Julie A Farley; Erik L Hodges; Junie P Warrington; Song Han; Kar-Ming Fung; Anna Csiszar; Zoltan Ungvari; William E Sonntag
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-08-06       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.